Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 11, 2020
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
Mon, February 10, 2020
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
Liana Moussatos Maintained (AQST) at Buy with Increased Target to $36 on, Feb 10th, 2020
Liana Moussatos of Wedbush, Maintained "Aquestive Therapeutics, Inc." (AQST) at Buy with Increased Target from $35 to $36 on, Feb 10th, 2020.
Liana has made no other calls on AQST in the last 4 months.
There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Liana's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liana
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $14 on, Monday, December 2nd, 2019
Similar Stocks and Investing Articles
[ Tue, Jan 28th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Wed, Jan 08th 2020
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI